ACHC · Acadia Healthcare Company, Inc.
$34.43
-0.07 (-0.20%)
At close · Jul 20
Market Cap
$3.17B
Shares
92.21M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$3.31B
+5%
FY2025
Net Income
-$1.1B
-531.4%
FY2025
Operating Margin
18.85%
-0.8pp
FY2019
Diluted EPS
-$12.16
-537.4%
FY2025
Operating Cash Flow
$131.9M
+1.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $3.37B | $3.31B | $3.15B | $2.93B | $2.61B | $2.31B | $2.09B | $3.11B | $3.01B | — | — | — | — | — | — | — | |
| -$148.01M | -$138.86M | -$116.37M | -$82.13M | -$69.76M | -$76.99M | -$158.11M | -$187.09M | -$185.41M | -$176.01M | -$181.33M | -$106.74M | -$48.22M | -$37.25M | — | — | |
| — | $177.6M | $156.8M | $153.3M | $124.3M | $108.2M | $97.8M | $90.4M | $86.6M | $76.4M | $86.8M | $68.3M | $36.9M | $29M | $21.6M | — | |
| — | — | — | — | — | — | — | — | — | $400K | $400K | $500K | $600K | $800K | $600K | — | |
| $194.64M | $189.25M | $149.6M | $132.35M | $117.77M | $106.72M | $95.26M | $164.04M | $158.83M | $143.01M | $135.1M | $63.55M | $32.67M | $17.09M | $7.98M | $4.28M | |
| $2.99B | — | — | — | — | — | — | $2.97B | $3.18B | $2.6B | $2.78B | $1.63B | $878.45M | $644.16M | $374.63M | $254.96M | |
| $4.44B | $4.38B | $2.81B | $2.95B | $2.24B | $2.04B | $1.91B | — | — | — | — | — | — | — | — | — | |
| $582.73M | — | — | — | — | — | — | $585.88M | $593.58M | $604.36M | $608.59M | $404.83M | $215.49M | — | — | — | |
| — | — | — | — | — | — | — | 18.85% | 19.7% | — | — | — | — | — | — | — | |
| $671.75M | — | — | — | — | — | — | $749.93M | $752.41M | $747.37M | $743.69M | $468.38M | $248.16M | — | — | — | |
| $35.26M | — | — | — | — | — | — | — | — | — | — | — | — | — | $29.77M | $9.19M | |
| -$1.07B | -$1.07B | $341.88M | -$25.36M | $374.14M | $275.76M | $183.8M | $135.99M | -$168.95M | $236.8M | $32.96M | $164.75M | $126.15M | $69.25M | $32.83M | -$38.47M | |
| $28.08M | $25.98M | $77.4M | -$9.7M | $94.11M | $67.56M | $40.61M | $25.87M | $6.53M | $37.21M | $28.78M | $53.39M | $42.92M | $25.98M | $12.33M | -$5.27M | |
| — | -$1.1B | $255.61M | -$21.67M | $273.14M | $190.64M | -$672.13M | $108.92M | -$175.75M | $199.84M | $6.14M | $112.55M | $83.04M | $42.58M | $20.4M | -$34.89M | |
| — | -33.29% | 8.1% | -0.74% | 10.46% | 8.24% | -32.16% | 3.51% | -5.83% | — | — | — | — | — | — | — | |
| $10.52M | $10.85M | $8.87M | $6.01M | $6.89M | $4.93M | $2.93M | $1.2M | $264K | -$246K | -$1.97M | -$1.08M | — | — | — | — | |
| — | — | — | -$21.67M | $273.14M | $562M | -$628.61M | $156.42M | -$264.01M | $375.29M | -$438.78M | $76.28M | — | — | — | — | |
| USD/shares | — | -$12.16 | $2.79 | -$0.24 | $3.05 | $2.15 | -$7.65 | $1.24 | -$2.01 | $2.30 | $0.07 | $1.65 | $1.51 | $0.85 | $0.53 | -$1.86 |
| USD/shares | — | -$12.16 | $2.78 | -$0.24 | $2.98 | $2.10 | -$7.59 | $1.24 | -$2.01 | $2.30 | $0.07 | $1.64 | $1.50 | $0.85 | $0.53 | -$1.86 |
| shares | — | 90.71M | 91.62M | 90.95M | 89.68M | 88.77M | 87.88M | 87.61M | 87.29M | 86.95M | 85.7M | 68.09M | 55.06M | 50M | 38.48M | 18.76K |
| shares | — | 90.71M | 92.06M | 90.95M | 91.56M | 90.79M | 88.6M | 87.82M | 87.29M | 87.06M | 85.97M | 68.39M | 55.33M | 50.26M | 38.7M | 18.76K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
1.64×
Medical Care Facilities median 1.28×
EV/EBIT
—
Medical Care Facilities median 18.56×
P/E (TTM)
—
Medical Care Facilities median 16.84×
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| United States Facilities | $3,312,769,000 | $3,153,963,000 | $2,928,738,000 | $2,610,399,000 | $2,314,394,000 | $2,089,929,000 | $2,008,381,000 | $1,904,695,000 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Acute Inpatient Psychiatric Facilities | $1,830,324,000 | $1,678,266,000 | $1,489,248,000 | $1,330,757,000 | $1,126,872,000 | $984,609,000 | $912,097,000 | $814,124,000 |
| Specialty Treatment Facilities | $567,196,000 | $592,023,000 | $614,220,000 | $564,671,000 | $510,929,000 | $452,805,000 | $788,232,000 | $761,017,000 |
| Comprehensive Treatment Centers | $567,176,000 | $537,886,000 | $500,242,000 | $419,940,000 | $385,635,000 | $349,217,000 | — | — |
| Residential Treatment Centers | $348,073,000 | $345,788,000 | $325,028,000 | $295,031,000 | $283,169,000 | $281,158,000 | $286,959,000 | $293,053,000 |
| Outpatient Communitybased Facilities | — | — | — | — | — | — | — | $36,501,000 |
| Product And Service Other | — | — | — | — | $7,789,000 | $22,140,000 | $21,093,000 | — |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2019 | FY2018 | FY2017 |
|---|---|---|---|
| United States Facilities | $503,358,000 | $488,207,000 | $475,260,000 |
| United Kingdom Facility | $166,693,000 | $185,755,000 | $198,566,000 |
Operating Margin by Segment (%)
| Component | FY2019 | FY2018 |
|---|---|---|
| United States Facilities | 25.1% | 25.6% |